Tools and approaches to ensure quality of vaccines throughout the cold chain

References

• World Health Organization. State of the world’s vaccines and immunization, Geneva 2009. Available from: www.whqlibdoc.who.int/publications/2009/9789241563864_eng.pdf
   Google Scholar
• Arlington: public Broadcasting Service. Available from: www.pbs.org/wgbh/aso/databank/entries/dm79sp.html
   Google Scholar
• World Health Organization. Poliomyelitis. Fact sheet No. 114, Geneva, April 2013. Available from: www.who.int/mediacentre/factsheets/fs114/en/
   Google Scholar
• UNICEF, New York: Expanding immunization coverage. Available from: www.unicef.org/immunization/index_coverage.html
   Google Scholar
• cdc.gov [Internet] Atlanta: Centers for disease control and prevention. Global immunization strategic framework 2011-2015. Available from: www.cdc.gov/globalhealth/gid/framework/framework.html
   Google Scholar
• UNECA. Goal 4: Reduce child mortality. 2012. Available from: www1.uneca.org/Portals/mdgreports/2012/Goal04.pdf
   Google Scholar
• unicef.org [Internet] New York: young child survival and development. Available from: www.unicef.org/childsurvival/index_40850.html
   Google Scholar
• who.int [Internet] Geneva: World Health Organization. Number of countries having introduced Hib (containing) vaccines to date. Available from: www.who.int/nuvi/hib/Countries_Intro_HibV_Sep2012.ppt
   Google Scholar
• reportlinker.org [Internet] Lyon: reportLinker corporate. marketview: universal pneumo vaccines. Available from: www.reportlinker.com/p0961710/MarketVIEW-Universal-pneumo-vaccines.html
   Google Scholar
• vaccinenewsdaily.com [Internet] Chicago: Vaccine News Daily. Haiti introduces rotavirus vaccine into routine immunization program. Available from: www.vaccinenewsdaily.com/vaccine_development/324490-haiti-introduces-rotavirus-vaccine-into-routine-immunization-program/
   Google Scholar
• World Health Organization, Global vaccine action plan 2011-2020. Geneva 2013. Available from: www.who.int/iris/bitstream/10665/78141/1/9789241504980_eng.pdf
   Google Scholar
• Levine OS, Bloom DE, Cherian T, et al. The future of immunisation policy, implementation, and financing. Lancet 2011;378(9789):439-48
   PubMed Web of Science ®Google Scholar
• World Health Organization. Children: reducing mortality. WHO Fact sheet no. 178. 2012. Available from: www.who.int/mediacentre/factsheets/fs178/en/
   Google Scholar
• Burton A, Monasch R, Lautenbach B, et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009;87:535-41
   PubMed Web of Science ®Google Scholar
• United Nations/AGECC. Energy for a sustainable future: summary report and recommendations, 2010. New York. Available from: www.un.org/wcm/webdav/site/climatechange/shared/Documents/AGECC%20summary%20report%5B1%5D.pdf
   Google Scholar
• Kurzatkowski W, Kartoglu U, Staniszewska M, et al. Structural damages in adsorbed vaccines affected by freezing. Biologicals 2013;41(2):71-6
   PubMed Web of Science ®Google Scholar
• McColloster PJ. US vaccine refrigeration guidelines: loose links in the cold chain. Hum Vaccin 2011;7:574-5
   PubMed Web of Science ®Google Scholar
• Levinson DR. Vaccines for children program: vulnerabilities in vaccine management. Department of Health and Human Services, Office of Inspector General. 2012. OEI-04-10-00430 Available from: www.oig.hhs.gov/oei/reports/oei-04-10-00430.pdf
   Google Scholar
• Wirkas T, Toikilik S, Miller N, et al. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 2007;25:691-7
   PubMed Web of Science ®Google Scholar
• Matthias DM, Robertson J, Garrison MM, et al. Freezing temperatures in the vaccine cold chain: a systematic review. Vaccine 2007;25:3980-6
   PubMed Web of Science ®Google Scholar
• Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine 2007;25:1328-33
   PubMed Web of Science ®Google Scholar
• Parenteral Drug Association (PDA). Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Bethesda (MD) Parenteral Drug Association (PDA) PDA J Pharm Sci Technol 2007; Report No. 39
   Google Scholar
• Afsar A, Kartoglu U. Vaccine stock management: guidelines for immunization and vaccine store managers. Geneva, 2006. WHO/IVB/06.12 Available from: www.whqlibdoc.who.int/hq/2006/WHO_IVB_06.12_eng.pdf
   Google Scholar
• Burgess MA, McIntyre PB. Vaccines and the cold chain: is it too hot...or too cold? Med J Aust 1999;171:82
   PubMed Web of Science ®Google Scholar
• Jeremijenko A, Kelly H, Sibthorpe B, Attewell R. Improving vaccine storage in general practice refrigerators. BMJ 1996;312:1651-2
   PubMedGoogle Scholar
• Bell KN, Hogue CJ, Manning C, Kendal AP. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001;107:e100
   Web of Science ®Google Scholar
• Gazmararian JA, Oster NV, Green DC, et al. Vaccine storage practices in primary health care physician offices. Am J Prev Med 2002;23(4):246-53
   PubMed Web of Science ®Google Scholar
• Nelson C, Froes P, Van Dyck AM, et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007;25:433-7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Requirements for poliomyelitis (oral). WHO Expert committee on biological standardization technical report series 40th report. Geneva 1989.800:Annex1. Available from: www.whqlibdoc.who.int/trs/WHO_TRS_800_(part1).pdf
   Google Scholar
• World Health Organization. Requirements for measles, mumps and rubella vaccines and combined vaccine (live). Expert committee on biological standardization technical report series 43rd report. Geneva 1992.840:Annex3. Available from: www.whqlibdoc.who.int/trs/WHO_TRS_840.pdf
   Google Scholar
• World Health Organization. Requirements for yellow fever vaccine. Expert committee on biological standardization, technical report series 46th Report. Geneva 1998.840:Annex2. Available from: www.whqlibdoc.who.int/trs/WHO_TRS_872.pdf
   Google Scholar
• World Health Organization. Quality of the cold chain: WHO/UNICEF policy statement on the use of vaccine vial monitors in immunization services (WHO/V&B/99.18). Available from: www.whqlibdoc.who.int/hq/1999/WHO_V&B_99.18.pdf
   Google Scholar
• Zipursky S, Boualam L, Cheikh DO, et al. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad. Vaccine 2011;29:5652-6
   PubMed Web of Science ®Google Scholar
• Halm A, Yalcouye I, Kamissoko M, et al. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali. Vaccine 2010;28:3467-72
   PubMed Web of Science ®Google Scholar
• World Health Organization. Getting started with vaccine vial monitors, Geneva 2002 (WHO/V&B/02.35). Available from: www.whqlibdoc.who.int/hq/2002/WHO_V&B_02.35.pdf
   Google Scholar
• Dietz V, Milstien JB, van Loon F, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 1996;74(6):619-28
   PubMed Web of Science ®Google Scholar
• Dietz V, Galazka A, van Loon F, Cochi S. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ 1997;75(1):81-93
   PubMed Web of Science ®Google Scholar
• Edstam JS, Dulmaa N, Tsendjav O, et al. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 2004;39:384-8
   PubMed Web of Science ®Google Scholar
• Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines 2009;8:547-57
   PubMed Web of Science ®Google Scholar
• Jezek J, Chen D, Watson L, et al. A heat-stable hepatitis B vaccine formulation. Hum Vaccin 2009;5(8):529-35
   PubMed Web of Science ®Google Scholar
• Schöndorf I, Banzhoff A, Nicolay U, Diaz-Mitoma F. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: a controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate®, stored at room temperature for 6 months. Vaccine 2007;25:1175-82
   PubMed Web of Science ®Google Scholar
• Le Tailec D, Doucet D, Elouahabi A, et al. CervarixTM, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions. Hum Vaccin 2009;5:467-74
   PubMedGoogle Scholar
• Milstien J, Kartoglu U, Zaffran M. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006. Available from: www.whqlibdoc.who.int/hq/2006/WHO_IVB_06.10_eng.pdf
   Google Scholar
• World Health Organization WPRO. Preventing mother-to-child transmission for hepatitis B. Operational Field Guidelines for delivery of the birth dose of Hepatitis B vaccines. Manila 2005.pp19-21. Available from: www.wpro.who.int/NR/rdonlyres/B8D1C444-C7B9-43B2-95A2-16ED87C94B0B/0/HepBBirthDoseFieldGuidelines.pdf
   Google Scholar
• World Health Organization. WHO-UNICEF policy statement on the implementation of vaccine vial monitors: the role of vaccine vial monitors in improving access to immunization. Geneva 2007 (WHO/IVB/07.04). Available from: www.who.int/immunization_standards/vaccine_quality/VVM_joint_statement_2007.pdf
   Google Scholar
• World Health Organization. Internet Geneva: WHO prequalified vaccines. Available from: www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/index.html
   Google Scholar
• World Health Organization. Assessing the programmatic suitability of vaccine candidates for WHO prequalification. Geneva 2012, WHO/IVB/12.10. Available from: www.apps.who.int/iris/bitstream/10665/76537/1/WHO_IVB_12.10_eng.pdf
   Google Scholar
• World Health Organization. Guidelines on stability evaluation of vaccines. Expert committee on biological standardization, technical report series 57th report. Geneva 2006;962:annex3
   Google Scholar
• Kartoglu U, Ganivet S, Guichard S, et al. Use of cool water packs to prevent freezing during vaccine transportation at the country level. PDA J Pharm Sci Technol 2009;63(1):11-26
   PubMedGoogle Scholar
• Kartoglu U, Ozguler NK, Wolfson LJ, Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Organ 2010;88:624-31
   PubMed Web of Science ®Google Scholar
• World Health Organization. Shake and tell–video article. Available from: www.vimeo.com/8381355
   Google Scholar
• World Health Organization. Step by step shake test-educational/instructional video. Available from: www.vimeo.com/8389435
   Google Scholar
• Murhekar MV, Dutta S, Kapoor AN, et al. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. Bull World Health Organ 2013;91:906-13. Available from: www.who.int/bulletin/volumes/91/12/13-119974.pdf
   PubMed Web of Science ®Google Scholar
• ISO 3100:2009 Risk management–Principles and guidelines
   Google Scholar
• ISO Guide 73:2009 Risk management–Vocabulary
   Google Scholar
• ISO/IEC 31010:2009 Risk management–Risk management techniques
   Google Scholar
• Vesper J. An overview of risk management process. In: Risk assessment and risk management in the pharmaceutical industry ( Chapter5). PDA/Davis Healthcare International Publishing; 2006
   Google Scholar
• Kaplan S, Garrick BJ. On the quantitative definition of risk. Risk Anal 1981;1:11-27
   Google Scholar
• Haimes YY. Total risk management. Risk Anal 1991;11(2):169-71
   Web of Science ®Google Scholar
• Stamatis DH. Failure mode and effect analysis. FMEA from theory to execution. American Society for Quality; 2003
   Google Scholar
• Vesely WE, Goldberg FF, Roberts NH, Haasl DF. Fault tree handbook. US Nuclear Regulatory Commisssion; 1981. NUREG-0492
   Google Scholar
• World Health Organization. Establishing and improving primary and intermediate vaccine stores. Geneva: 2002; WHO/V&B/02.34
   Google Scholar
• Kartoglu U. Asilarin optimal etkinliginin saglanmasi: Etkin asi yonetimi uygulamalari (ensuring the optimal potency of vaccines : effective vaccine management practices). In: Badur S, Bakir M, editors. Asi Kitabi (book of vaccines). Akademi Publishing, Turkey; 2012. p. 169-89
   Google Scholar
• Kartoglu U, Nelaj E, Maire D. Improving temperature monitoring in the vaccine cold chain at the periphery : an intervention study using a 30-day electronic refrigerator temperature logger (Fridge-tag). Vaccine 2010;28:4065-72
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO PQS prequalified devices and equipment E006 temperature monitoring devices. Internet Available from: www.apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/categorypage.aspx?id_cat=35
   Google Scholar
• World Health Organization. PQS performance specification for vaccine cold box. Geneva 2012 (WHO/PQS/E01/CB.01.3). Available from: www.apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/catdocumentation.aspx?id_cat=18
   Google Scholar
• World Health Organization. PQS performance specification for vaccine carrier. Geneva 2010 (WHO/PQS/E01/VC.01.2). Available from: www.apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/catdocumentation.aspx?id_cat=18
   Google Scholar
• World Health Organization. Technical review of vaccine vial monitor implementation. 27 March 2002, Geneva (unpublished report). Available from: www.who.int/immunization_standards/vaccine_quality/report_technical_review_of_vvm_implementation.pdf
   Google Scholar
• Baker P. Vaccine vial monitors: small labels with an immense impact. Case studies for global health. Alliance for case studies for global health. 2009; Available from: www.usp.org/sites/default/files/usp_pdf/EN/AUTMGHCaseStudies.pdf
   Google Scholar
• Frost LJ, Reich MR. Vaccine vial monitors: access to devices. In: Access: how do good health technologies get to poor people in poor countries? ( Chapter 7 Harvard Centre for population and development studies. 2008. Available from: www.accessbook.org/downloads/chapter_7_AccessBook.pdf
   Google Scholar
• Kartoglu U. Temperature sensitivity of the diphtheria containing vaccines, In: Priti R, editor. Insight and control of infectious disease in global scenario. In Tech 2012. Available from: www.intechopen.com/books/insight-and-control-of-infectious-disease-in-global-scenario/temperaturesensitivity-of-the-diptheria-containing-vaccines
   Google Scholar
• O’Donnell K. A year in the life of a vaccine (video). Extensio et Progressio, Authentic e-Learning and Global Learning Opportunities. Available from: www.vimeo.com/58148553
   Google Scholar
• Kristensen D. Thermostability of vaccines and the controlled temperature chain. In: Technet Kuala Lumpur consultation report. WHO; Geneva, Switzerland: 2010. p. 6
   Google Scholar
• Zaffran M, Dicko M, McCarney S, Lloyd J. Powering the cool chain: Addressing the challenges of vaccine delivery where it is needed most. Panel discussion at cold chain & temperature control distribution summit, May-June 2011. Available from: www.lanyrd.com/2011/coldchainonline/schedule/
   Google Scholar
• Shelley D. Report of the Immunization Practice Advisory Committee (IPAC) to SAGE. Geneva, 2012. Available from: www.who.int/immunization/sage/meetings/2012/november/IPAC.pdf
   Google Scholar
• Project Optimize. Delivering MenAfriVac using the Controlled Temperature Chain Approach. 2013. Available from: www.path.org/publications/files/TS_opt_menafrivac_photo_set.pdf
   Google Scholar
• WHO. Temperature controlled chain (CTC). Available from: www.who.int/biologicals/areas/vaccines/controlledtemperaturechain/en/
   Google Scholar
• Zaffran M, Vandelaer J, Kristensen D, et al. The imperative for stronger vaccine supply and logistics systems. Vaccine 2013;31S:B73-80
   Google Scholar
• EPELA, e-Pharmaceutical cold chain management. Available from: www.epela.net/epela_web/introduction.html
   Google Scholar
• EPELA, e-VVM based vaccine management. Available from: www.epela.net/epela_web/evvm.html
   Google Scholar
• Bishara R. Global perspectives in regulatory oversight. (video). Extensio et Progressio, Authentic e-Learning and Global Learning Opportunities. Available from: www.vimeo.com/51441317
   Google Scholar
• iata.org [Internet] Geneva. International Air Transport Association. Perishables and pharma. Available from: www.iata.org/whatwedo/cargo/pharma/Pages/index.aspx
   Google Scholar
• ich.irg [Internet] Geneva: International Conference on Harmonization. www.ich.org/products/guidelines/quality/article/quality-guidelines.html
   Google Scholar
• World Health Organization. Model guidance for the storage and transport of time- and temperature sensitive pharmaceutical products. WHO Expert committee on specifications for pharmaceutical preparations 45th report. WHO Technical Report Series. No.961;2011. Annex9
   Google Scholar
• Health Canada. Guidelines for temperature control of drug products during storage and transportation (GUI-0069). Available from: www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/compli-conform/gmp-bpf/docs/GUI-0069-eng.pdf
   Google Scholar
• European Union. Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01). Available from: www.eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:068:0001:0014:EN:PDF
   Google Scholar
• United States Pharmacopeia; <1079> Good storage and distribution practices for drug products. 2012
   Google Scholar
• United States Pharmacopeia; <1118> Monitoring devices-time, temperature and humidity. 2009
   Google Scholar
• United States Pharmacopeia; <1083> Good distribution practices-supply chain integrity. 2011
   Google Scholar
• IATA. Air transport logistics for time- and temperature-sensitive healthcare products. IATA 2009. Available from: https://www.iata.org/publications/Pages/temperature-control-regulations.aspx
   Google Scholar
• Dellepiane N, Griffiths E, Milstien JB. New challenges in assuring vaccine quality. Bull World Health Organ 2000;78(2):155-62
   PubMed Web of Science ®Google Scholar
• O’Donnell K. Changing the face of cold chain. Contract Pharma. 2011. Available from: www.contractpharma.com/issues/2011-11/view_advanced-degrees/changing-the-face-of-cold-chain-management/
   Google Scholar